The arrival of AI-generated research papers marks a turning point that could radically accelerate discovery—or drown it in ...
For investors wondering whether Thermo Fisher Scientific at around US$496 a share still offers solid value or if most of the ...
April 01, 2026 - PRESSADVANTAGE - As global clinical research and cross-border healthcare operations continue to ...
For the second year in a row, US President Donald Trump has proposed significant cuts to the budgets of major US science ...
Investor's Business Daily on MSN
Boston Scientific just took a 9% header. Why analysts are still bullish
Boston Scientific stock tumbled Monday on mixed test results for its Watchman device in patients at risk of having a stroke.
Zacks Investment Research on MSN
Boston Scientific (BSX) stock sinks as market gains: Here's why
Boston Scientific (BSX) ended the recent trading session at $61.86, demonstrating a -1.17% change from the preceding day's closing price. This change lagged the S&P 500's 0.08% gain on the day. On the ...
A robot named Adam was the first of its kind to do science. Adam mimicked a biologist. After coming up with questions to ask about yeast, the machine tested those questions inside a robotic laboratory ...
A new research incubator model empowers early-career scientists to lead independent programs, bypassing traditional academic hurdles.
A new editorial perspective was published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget: Past, Present and ...
ANNUAL RESULTS Annual revenue up 9% to €168 millionRoll-out of the Group’s strategy: Sales of proprietary products up 20%, accounting for 35% of revenueInternationalisation: 42% of revenue generated ...
Picture a world where every move you make at work is timed to the millisecond. Before Silicon Valley engineers worked on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results